Search Results 531-540 of 17080 for Lymphangiogenesis
The purpose of this study is to determine if study drug (BMS-986020) dose of 600 mg once daily or 600 mg twice daily for 26 weeks compared with placebo will ...
About this study. Study BRT-DA01-301 is a Phase 3 multicenter, randomized, sham surgery-controlled, double-blind study to assess efficacy and safety of ...
The purpose of this study is to use pembrolizumab for patients with relapsed or hard to treat classical Hodgkins Lymphoma. The primary study hypothesis is that ...
The purpose of this study is to determine the completion rate of an on demand, virtual stress reduction program (MBSR) in patients with cancer that are ...
About this study. The purpose of this study is to evaluate infliximab drug levels and anti-infliximab antibody levels in HiSCR50/IHS4 responders versus ...
Learn about the symptoms, risk factors and treatment of this cancer of the lymphatic system that causes swollen lymph nodes.
What is the incidence and etiology of bone overgrowth in protein versus other bone graft? Participation eligibility. Participant eligibility includes age, ...
Research. Mayo Clinic physician-scientists and researchers are committed to developing better treatments for people with disorders of the larynx and trachea ...
Read news highlighting gene studies in Parkinson's disease from Mayo Clinic's Translational Cell Biology of Parkinson's Disease Lab led by Wolfdieter ...
The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.